Charles Taylor (LON:CTR) had its price objective upped by Liberum Capital from GBX 330 ($4.48) to GBX 385 ($5.22) in a report issued on Friday. The brokerage presently has a “buy” rating on the stock. Liberum Capital’s target price would suggest a potential upside of 33.22% from the stock’s previous close.
Several other brokerages have also commented on CTR. Numis Securities restated an “add” rating and set a GBX 312 ($4.23) price target on shares of Charles Taylor in a research note on Wednesday, March 14th. Peel Hunt restated a “hold” rating on shares of Charles Taylor in a research note on Thursday, May 3rd.
Get Charles Taylor alerts:
Shares of LON:CTR opened at GBX 289 ($3.92) on Friday. Charles Taylor has a 12 month low of GBX 219.60 ($2.98) and a 12 month high of GBX 299 ($4.06).
Charles Taylor Company Profile
Charles Taylor plc provides professional services to the insurance market in the United Kingdom, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates through Management Services, Adjusting Services, and Insurance Support Services businesses. The Management Services business provides management services to insurance companies and associations.